Sector
PharmaceuticalsOpen
₹384.95Prev. Close
₹381.95Turnover(Lac.)
₹271.66Day's High
₹387.5Day's Low
₹382.5552 Week's High
₹537.752 Week's Low
₹330.85Book Value
₹282.79Face Value
₹10Mkt Cap (₹ Cr.)
2,250.18P/E
22.36EPS
17.08Divi. Yield
1.31Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 58.71 | 58.71 | 58.71 | 58.71 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,552.62 | 1,447.84 | 1,331.56 | 1,201.72 |
Net Worth | 1,611.33 | 1,506.55 | 1,390.27 | 1,260.43 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 2,184.02 | 1,966.98 | 1,894.47 | 983.3 |
yoy growth (%) | 11.03 | 3.82 | 92.66 | 38.36 |
Raw materials | -1,570.51 | -1,102.84 | -1,065.01 | -695.28 |
As % of sales | 71.9 | 56.06 | 56.21 | 70.7 |
Employee costs | -141.3 | -115.55 | -97.2 | -56.1 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 236.77 | 571.39 | 533.24 | 31.3 |
Depreciation | -43.26 | -38.92 | -35.73 | -30.21 |
Tax paid | -57.18 | -126.83 | -171.95 | -3.6 |
Working capital | -112.32 | 268.04 | 207.28 | -4.75 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 11.03 | 3.82 | 92.66 | 38.36 |
Op profit growth | -56.69 | 3.12 | 362.95 | 21.29 |
EBIT growth | -57.54 | 4.15 | 479.37 | 29.94 |
Net profit growth | -62.73 | 23.04 | 1,204.29 | 493.14 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|
Gross Sales | 2,132.79 | 2,217.11 | 2,184.02 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 2,132.79 | 2,217.11 | 2,184.02 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 30.07 | 25.61 | 32.04 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,808.55 | 157.37 | 4,33,847.75 | 863.29 | 0.75 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,255.35 | 90.32 | 1,65,923.17 | 518 | 0.48 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,507.7 | 28.77 | 1,21,796.04 | 1,178.16 | 0.86 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,339.15 | 69.06 | 1,12,981.55 | 460 | 0.84 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,616.45 | 52.27 | 1,04,785.17 | 634.43 | 0 | 2,529.74 | 269.23 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Varinder Gupta
Non-Exec. & Independent Dir.
Sandhya Mehta
Joint Managing Director
Vikas Gupta
Chairman & Independent Directo
Rajender Mohan Malla
Non-Exec. & Independent Dir.
Harpal Singh
Company Sec. & Compli. Officer
Abhay Raj Singh
Director (Works)
Kushal Kumar Rana
Non-Exec. & Independent Dir.
SHARAD TYAGI
Executive Director
Abhiraj Gupta
Additional Director
Rajni Jha
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by IOL Chemicals & Pharmaceuticals Ltd
Summary
IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active PharmaceuticalIngredient (API) and specialty chemicals sectors. With substantive manufacturing capacities, the Company benefits from economiesof scale and cost supremacy. Its extensive expertise in both API and specialty chemicals strengthens its business model and opens doors to diversified growth opportunities.Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines. It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories.In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride. The Company is a leader in fostering green chemistry through its extensive production of Ethyl Acetate, a sustainable and environmentally friendly solvent. As one of the largest manufacturers globally, the Company plays a vital role in promoting the adoption of eco-friendly practices in various industries such as pharmaceuticals, printing, flexible packaging, adhesives, surface coatings, flavors, paints & lamination, and essences.The company has two manufacturing units namely API Unit and Chemical Unit located in Punjab. A
Read More
The IOL Chemicals & Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹383.3 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of IOL Chemicals & Pharmaceuticals Ltd is ₹2250.18 Cr. as of 03 Dec ‘24
The PE and PB ratios of IOL Chemicals & Pharmaceuticals Ltd is 22.36 and 1.35 as of 03 Dec ‘24
The 52-week high/low is the highest and lowest price at which a IOL Chemicals & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of IOL Chemicals & Pharmaceuticals Ltd is ₹330.85 and ₹537.7 as of 03 Dec ‘24
IOL Chemicals & Pharmaceuticals Ltd's CAGR for 5 Years at 17.46%, 3 Years at -5.61%, 1 Year at -16.12%, 6 Month at 5.99%, 3 Month at -12.52% and 1 Month at -3.39%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice